Health Encyclopedia

 

Health Encyclopedia Home



Could Antidepressant Combat Lethal Lung Cancer?

Could Antidepressant Combat Lethal Lung Cancer?

FRIDAY, Sept. 27 (HealthDay News) -- An older and little-used class of antidepressants may help combat a particularly deadly form of lung cancer, according to a new study.

Using a unique computer program, researchers from the Stanford University School of Medicine identified tricyclic antidepressants as a potential treatment for small cell lung cancer. This class of drugs was introduced decades ago and is still approved for use in the United States, but has been supplanted by newer antidepressants with fewer side effects.

Follow-up experiments showed that the tricyclic antidepressant called imipramine (Tofranil), was effective against human small cell lung cancer cells grown in the laboratory and growing as tumors in mice. The drug activated a self-destruction pathway in the cancer cells and slowed or blocked the spread of cancer in mice.

Imipramine maintained its effectiveness regardless of whether the cancer cells had previously been exposed, and become resistant, to traditional chemotherapy treatments, according to the study, which was published online Sept. 27 in the journal Cancer Discovery.

Because tricyclic antidepressants already have U.S. Food and Drug Administration approval for use in people, the Stanford team was quickly able to launch a clinical trial to test imipramine in patients with small cell lung cancer and certain other types of cancer. They are currently recruiting patients for the phase-2 trial.

"We are cutting down the decade or more and the $1 billion it can typically take to translate a laboratory finding into a successful drug treatment to about one to two years and spending about $100,000," study co-senior author Dr. Atul Butte, director of the Center for Pediatric Bioinformatics at Lucile Packard Children's Hospital at Stanford, said in a university news release.

"The five-year survival for small cell lung cancer is only 5 percent," study co-senior author Julien Sage, an associate professor of pediatrics, said in the news release. "There has not been a single efficient therapy developed in the last 30 years. But when we began to test these drugs in human cancer cells grown in a dish and in a mouse model, they worked, and they worked, and they worked."

Another drug, an antihistamine called promethazine (Phenergan), also exhibited the ability to kill cancer cells, according to the researchers.

More information

The U.S. National Cancer Institute has more about small cell lung cancer.

SOURCE: Stanford Unversity, news release, Sept. 26, 2013

 
Related Items
Wellness Library
  When and How to Stop Antidepressant Medication
  For Adults: Take Care with Antidepressants
  Depressed Kids Need Help
Drug Reference
  Trimipramine
Daily News Feed
  'Exposure Therapy' Along With Antidepressants May Help With OCD
  Mental State Influences Readmission After Heart Failure Treatment, Study Says
  Variant of Club Drug 'K' Might Have New Life as Antidepressant
  Taking Antidepressants During Pregnancy May Not Raise Autism Risk
  Antidepressant Use During Pregnancy Not Linked to Autism
  Meditation May Reduce Mild Depression, Anxiety
  Primary Care Providers May Balk at Giving Teens Antidepressants
  Antidepressants in Pregnancy Tied to Slight Risk of Lung Disorder in Babies
  Early Treatment for Depression May Be Good for the Heart
  Antidepressant Celexa May Help Ease Alzheimer's-Linked Agitation
  Study Ties Antidepressant Use in Pregnancy to Autism Risk in Boys
  Prescription Drug Use Continues to Climb in U.S.
  Could Certain Antidepressants Slow Alzheimer's?
  Antidepressant Eases Menopause-Related Symptoms, Study Finds
  Antidepressants in Pregnancy Won't Harm Baby's Heart, Study Suggests
Adult Diseases and Conditions
  Perimenopause
Pediatric Diseases and Conditions
  Major Depression in Adolescents